Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
Enquiries regarding human consumption cannot be answered
Learn more about how AI Is revolutionizing dementia detection and treatment
authorities have started to crack down: FDA Warning on Safety Risks: In late 2023, the FDA explicitly flagged BPC-157 as an unsafe compound to use in compounding
When any component fails, oral supplementation becomes far less effective, potentially requiring massive doses to achieve therapeutic blood levels
US$ 25.21
US$ 23.88
US$ 26.52
US$ 21.97
US$ 23.67
US$ 22.20
US$ 21.20
US$ 26.40
US$ 23.10
US$ 29.91
US$ 21.82
US$ 27.27
